Hyperimmunoglobulinemia and Rate of HIV Type 1 Infection Progression

AIDS Research and Human Retroviruses

Volumn 20, Issue 1, 2004, Pages 127-128

  Abelian, Arthur ^a   Burling, Keith ^b   Easterbrook, Philippa ^c   Winter, Greg ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

B LYMPHOCYTE ACTIVATION; CELL COUNT; COHORT ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERIMMUNOGLOBULINEMIA; LETTER; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

DISEASE PROGRESSION; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULINS;

EID: 0742290174     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922204322749576     Document Type: Letter

References (13)

1. van Furth R, Schuit HR, and Hijmans W: The formation of immunoglobulins by human tissues in vitro. IV. Circulating lymphocytes in normal and pathological conditions. Immunology 1966;11:29-40.
2. Stahl RE, Friedman-Kien A, Dubin R, Marmor M, and Zolla-Pazner S: Immunologic abnormalities in homosexual men. Relationships to Kaposi's sarcoma. Am J Med 1982;73:171-178.
3. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, and Fauci AS: Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983;309:453-458.
4. Katz IR, Krown SE, Safai B, Oettgen HF, and Hoffman MK: Antigen-specific and polyclonal B-cell responses in patients with acquired immunodeficiency disease syndrome. Clin Immunol Immunopathol 1986;39:359-367.
5. Mizuma H, Zolla-Pazner S, Litwin S, et al.: Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses. Clin Immunol Immunopathol 1987;68:5-14.
6. Jacobson DL, McCutchan JA, Spechko PL, et al.: The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. J Infect Dis 1991;163:240-246.
7. Amadori A, Zamarchi R, Ciminale V, et al.: HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol 1989;143:2146-2152.
8. Shirai A, Cosentino M, Leitman-Klinman SF, and Klinman DM: Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest 1992;89:561-566.
9. Reimer CB, Black CM, Holman RC, et al.: Hypergammaglobulinemia associated with human immunodeficiency virus infection. Monogr Allergy 1988;23:83-96.
10. Binley JM, Klasse PJ, Cao Y, et al.: Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol 1997;71:2799-2809.
11. Morris L, Binley JM, Clas BA, et al.: HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 1998;188:233-245.
12. Jacobson MA, Khayam-Bashi H, Martin JN, Black D, and Ng V: Effect of long-term highly active therapy in restoring HIV-induced abnormal B-lymphocyte function. J Acquir Immune Defic Syndr 2002;31:472-477.
13. Hunziker L, Recher M, Macpherson AJ, et al.: Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat Immunol 2003;4:343-349.